Godavari Drugs

Godavari Drugs

86.40
+1.86
(2.20%)
ann
There are new updates from the company21 hours ago
Viewcross
right
Market Cap
65.20 Cr
EPS
5.82
PE Ratio
17.20
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
142.50
52 Week Low
79.00
PB Ratio
1.50
Debt to Equity
1.48
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
negative
Godavari Drugs Reports Q1 Results, Doubles Authorized Share Capital to ₹20 CroreAug 13, 2025
Godavari Drugs Limited reported unaudited financial results for the quarter ended June 30, 2025. The company posted revenue from operations of ₹2,381.13 lakhs compared to ₹3,220.75 lakhs in the same quarter last year. Net profit for the quarter was ₹104.06 lakhs versus ₹153.08 lakhs in the corresponding period last year. Earnings per share stood at ₹1.38 compared to ₹2.17 in the previous year quarter. The Board approved increasing the company's authorized share capital from ₹10 crore to ₹20 crore by creating an additional 1 crore equity shares of ₹10 each, subject to shareholder approval. The company also rescheduled its 37th Annual General Meeting from August 28, 2025 to September 27, 2025.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,586.70
#1 3,80,702.50
33.18
#1 54,729.00
9.71
#1 10,980
-19.84
51.86
5,689.50
1,51,038.30
65.50
9,712.00
18.67
2,191
26.74
36.39
1,499.40
1,21,107.70
22.45
28,409.50
7.12
5,291
9.88
38.89
3,561.00
1,20,520.40
59.72
11,539.40
6.99
1,911
19.91
42.61
1,253.10
1,04,580.10
#1 18.40
33,741.20
16.73
5,725
1.26
46.51
2,482.90
1,02,476.40
54.18
12,744.20
#1 20.90
2,007
-18.14
44.66
975.00
98,107.80
21.07
23,511.00
18.55
4,615
2.60
50.50
1,919.80
87,676.40
23.72
22,909.50
13.74
3,306
#1 51.64
46.16
5,433.00
64,959.70
28.53
13,458.30
3.70
2,216
21.39
61.31
1,090.00
63,307.40
18.84
32,345.60
9.43
3,484
-10.24
53.78
Forecast
Actual
Growth Rate
Revenue Growth
-27.34 %
Net Income Growth
-20.00 %
Cash Flow Change
39.26 %
ROE
-29.07 %
ROCE
-34.05 %
EBITDA Margin (Avg.)
26.55 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
Revenue
55
71
76
65
84
96
123
161
160
157
114
105
Expenses
49
67
70
60
78
90
113
150
150
143
102
94
EBITDA
6
5
6
5
6
6
10
12
11
14
13
12
Operating Profit %
11 %
6 %
7 %
6 %
7 %
6 %
8 %
7 %
6 %
8 %
10 %
11 %
Depreciation
1
1
1
1
1
1
1
2
2
2
2
3
Interest
1
2
3
2
3
3
3
3
4
5
5
4
Profit Before Tax
5
2
3
1
2
2
6
7
5
7
6
5
Tax
1
1
1
1
1
0
2
2
1
1
1
1
Net Profit
4
1
2
1
1
2
4
5
4
6
4
4
EPS in ₹
4.84
1.79
2.40
1.10
1.60
2.66
5.48
6.97
5.03
7.37
5.82
5.00

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
35
51
56
63
74
84
91
101
121
135
143
Fixed Assets
7
9
13
15
15
14
22
26
25
27
33
Current Assets
27
40
43
47
57
61
68
74
87
89
79
Capital Work in Progress
0
1
0
1
2
9
1
1
9
18
30
Investments
0
0
0
0
0
0
0
0
0
0
0
Other Assets
27
41
43
48
57
61
68
75
87
90
81
Total Liabilities
35
51
56
63
74
84
91
101
121
135
143
Current Liabilities
17
31
34
37
46
51
51
58
74
82
73
Non Current Liabilities
5
5
6
9
9
12
16
14
14
14
27
Total Equity
13
14
16
17
18
20
24
30
33
39
43
Reserve & Surplus
6
7
9
10
11
13
17
22
26
31
36
Share Capital
8
8
8
8
8
8
8
8
8
8
8

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
0
0
1
-0
-0
0
1
1
-1
Investing Activities
-0
-2
-3
-3
-2
-7
-1
-5
-9
-13
Operating Activities
-6
-5
5
4
4
6
1
11
13
18
Financing Activities
6
7
-2
-0
-2
0
0
-6
-4
-6

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
55.86 %
56.13 %
56.13 %
56.13 %
56.36 %
56.92 %
56.92 %
53.12 %
53.12 %
53.16 %
53.16 %
53.16 %
53.16 %
53.16 %
52.63 %
52.63 %
52.63 %
52.63 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
36.16 %
36.05 %
36.33 %
36.14 %
35.59 %
35.87 %
35.90 %
39.27 %
7.27 %
38.75 %
38.99 %
38.87 %
39.10 %
38.96 %
39.76 %
39.98 %
39.93 %
37.09 %
Others
7.49 %
7.32 %
7.05 %
7.23 %
7.56 %
6.71 %
6.68 %
7.12 %
39.11 %
7.59 %
7.35 %
7.47 %
7.24 %
7.38 %
7.11 %
6.89 %
6.95 %
9.78 %
No of Share Holders
0
4,136
4,567
5,394
5,750
6,034
6,232
5,968
6,555
6,561
7,019
6,894
7,005
7,044
7,709
7,915
7,881
7,828

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
29 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Aug 2024 91.80 139.65
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 122.50 117.20
12 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Feb 2025 102.90 101.35
29 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 May 2025 98.48 97.99
13 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Aug 2025 82.85 86.51
27 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Sept 2025 82.57 86.51

Announcements

Shareholder Meeting / Postal Ballot-Outcome of AGM21 hours ago
Closure of Trading Window9 days ago
Dispatch Of Letter To ShareholdersSep 04, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 04, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 04, 2025
Notice Of 37Th Annual General Meeting Of The CompanySep 03, 2025
Reg. 34 (1) Annual Report.Sep 03, 2025
Intimation Of Book Closure For The Purpose Of 37Th Annual General MeetingSep 02, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 02, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2025
Shareholder Meeting / Postal Ballot - 37Th Annual General Meeting Scheduled On 27Th September 2025Aug 13, 2025
Un-Audited Financial Results For The Period Ended 30.06.2025Aug 13, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th August 2025Aug 13, 2025
Rescheduling Of 37Th Annual General Meeting (AGM) Of The CompanyAug 01, 2025
Board Meeting Intimation for Unaudited Standalone Financial Results Of The Company For The First Quarter Ended 30Th June 2025 And Rescheduling Of 37Th Annual General Meeting (AGM) Of The CompanyAug 01, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 15, 2025
Closure of Trading WindowJun 25, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 31, 2025
INTIMATION FOR RE-CONSTITUTION OF COMMITTEES OF THE BOARDMay 29, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 29, 2025
AUDITED STANDALONE FINANCIALS OF THE COMPANY FOR THE QUARTER AND YEAR ENDED ON 31-03-2025May 29, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Of Godavari Drugs Limited Held On Thursday 29Th May 2025 Ref: Reg. 30 Read With Reg. 33 Of SEBI (LODR) Regulations 2015 May 29, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2025
Board Meeting Intimation for Approval Of The Audited Financial Results Of The Company Along With Audit Report For The Quarter And Year Ended On 31.03.2025 And Induction Of New Director On The Board Of The CompanyMay 24, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 14, 2025
Closure of Trading WindowMar 27, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 13, 2025
Integrated Filing (Financial)Feb 12, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Of Godavari Drugs Limited (The Company) Held On Wednesday 12Th February 2025Feb 12, 2025
Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024Feb 12, 2025
Board Meeting Intimation for Intimation Of The Board Meeting Of Godavari Drugs Limited (The Company) To Be Held On Wednesday February 12 2025.Feb 06, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 20, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateJan 02, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 31, 2024
Closure of Trading WindowDec 31, 2024
Submission Of Revised Certificate Under Regulation 40(10) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations 2015) For The Financial Year Ended 31Dec 23, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 15, 2024
Unaudited Financial Results For Quarter And Half-Year Ended September 30, 2024Nov 14, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Of Godavari Drugs Limited (The Company) Held On Thursday 14Th November, 2024Nov 14, 2024
Board Meeting Intimation for Intimation For Board MeetingNov 08, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 15, 2024
Closure of Trading WindowSep 30, 2024
Reg. 34 (1) Annual Report.Sep 05, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''''s ReportSep 02, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 29, 2024
Clarification On Share Price MovementAug 29, 2024
Clarification Sought from Godavari Drugs LtdAug 28, 2024
Un-Audited Financial Results For The Quarter Ended On 30.06.2024Aug 14, 2024
Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended On 30.06.2024Aug 09, 2024
Newspaper Advertisement Titled 'Notice Of The 36Th Annual General Meeting And E-Voting Information'Aug 09, 2024

Technical Indicators

RSI(14)
Neutral
56.04
ATR(14)
Volatile
3.85
STOCH(9,6)
Neutral
34.95
STOCH RSI(14)
Neutral
56.53
MACD(12,26)
Bullish
0.21
ADX(14)
Weak Trend
24.62
UO(9)
Bearish
35.16
ROC(12)
Uptrend And Accelerating
3.49
WillR(14)
Neutral
-42.00